Digital Breast Tomosynthesis Market Report 2026

The digital breast tomosynthesis market size has grown rapidly in recent years. It will grow from $2.74 billion in 2025 to $3.12 billion in 2026 at a compound annual growth rate (CAGR) of 14%. The growth in the historic period can be attributed to increasing prevalence of breast cancer cases, rising adoption of digital mammography systems, growing awareness of early cancer detection, expansion of hospital diagnostic infrastructure, increasing government screening programs.

The digital breast tomosynthesis market size is expected to see rapid growth in the next few years. It will grow to $5.31 billion by 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to growing demand for precision oncology diagnostics, increasing integration of ai in medical imaging, rising adoption of 3d imaging technologies in healthcare, expansion of breast cancer screening coverage in emerging economies, increasing investment in advanced radiology systems. Major trends in the forecast period include increasing adoption of ai-assisted image reconstruction in dbt systems, rising demand for low-dose breast imaging technologies, growing integration of advanced radiology workstations for 3d visualization, expansion of hybrid 2d/3d mammography systems in diagnostic centers, rising use of portable and mobile tomosynthesis units in screening programs.

The increasing prevalence of breast cancer is expected to propel the growth of the digital breast tomosynthesis market going forward. Breast cancer is a condition in which abnormal cells within the breast proliferate uncontrollably and form a tumor. The rise in breast cancer cases is primarily driven by lifestyle-related changes, particularly delayed childbirth and reduced breastfeeding practices. Digital breast tomosynthesis supports breast cancer detection by delivering advanced three-dimensional breast imaging, which improves diagnostic accuracy, especially in dense breast tissue, thereby enabling earlier and more reliable diagnosis as screening demand increases. For instance, in October 2023, according to NHS East Genomics, a UK-based public-sector healthcare partnership, approximately 55,900 new breast cancer cases are diagnosed annually in the UK. Therefore, the increasing prevalence of breast cancer is driving the growth of the digital breast tomosynthesis market.

Key companies operating in the digital breast tomosynthesis market are focusing on developing breast imaging analysis, such as 50-degree wide-angle digital breast tomosynthesis acquisition, to enhance image resolution, improve lesion detectability, and enable faster and more accurate breast cancer diagnosis. A 50-degree wide-angle digital breast tomosynthesis acquisition refers to an advanced breast imaging technique in which X-ray projections are captured across a wide 50-degree arc around the breast, allowing the system to reconstruct highly detailed three-dimensional images with improved depth resolution and lesion visibility. For example, in May 2025, Siemens Healthineers AG, a Germany-based medical technology company, launched the MAMMOMAT B.brilliant, an advanced digital breast imaging system designed to enhance diagnostic accuracy and workflow efficiency. The MAMMOMAT B.brilliant by Siemens Healthineers AG features advanced 50-degree wide-angle digital breast tomosynthesis that enhances lesion detection and diagnostic confidence. It offers optimized low-dose technology for safer screening while maintaining high image quality.

In July 2025, DeepHealth Inc., a US-based AI-powered health informatics and radiology clinical AI solutions company, acquired iCAD Inc. for an undisclosed amount. Through this acquisition, DeepHealth Inc. aims to enhance its AI-driven breast imaging and oncology portfolio by integrating advanced cancer detection technologies, improving diagnostic accuracy, and expanding its presence in the global medical imaging market. iCAD Inc. is a US-based provider of AI-powered cancer detection solutions, including CAD/AI software solutions for breast imaging.

Major companies operating in the digital breast tomosynthesis market are Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Konica Minolta Inc., Hologic Inc., Shimadzu Corporation, Agfa-Gevaert N.V., Varex Imaging Corporation, Analogic Corporation, Trivitron Healthcare Private Limited, Anke Medical Equipment Co. Ltd., Allengers Medical Systems Limited, Planmed Oy, Novarad Corporation, Genoray Co. Ltd., General Medical Merate S.p.A., Guangzhou Ysenmed Equipment Co. Ltd., Metaltronica S.p.A., Internazionale Medico Scientifica S.r.l.

North America was the largest region in the digital breast tomosynthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital breast tomosynthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital breast tomosynthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital breast tomosynthesis market consists of revenues earned by entities by providing services such as breast cancer screening, diagnostic imaging, radiology analysis, and imaging system maintenance and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital breast tomosynthesis market also includes sales of tomosynthesis mammography systems, 3D imaging detectors, image reconstruction software, workstations, and related imaging accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.